X4 Pharmaceuticals (XFOR) Other Non-Current Assets (2017 - 2025)

X4 Pharmaceuticals (XFOR) has 9 years of Other Non-Current Assets data on file, last reported at $692000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Assets fell 66.73% year-over-year to $692000.0; the trailing twelve-month figure through Dec 2025 stood at $692000.0 (down 66.73% YoY), and the FY2025 full-year result was $692000.0, down 66.73% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $692000.0, down from $2.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.0 million in Q1 2025 and bottomed at $692000.0 in Q4 2025.
• The 5-year median for Other Non-Current Assets is $1.8 million (2021), against an average of $1.7 million.
• Peak annual rise in Other Non-Current Assets reached 101.94% in 2025, while the deepest fall reached 66.73% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $1.7 million in 2021, then fell by 28.9% to $1.2 million in 2022, then gained by 17.22% to $1.4 million in 2023, then surged by 44.85% to $2.1 million in 2024, then tumbled by 66.73% to $692000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $692000.0 (Q4 2025), $2.0 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.

Peer Comparison